Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial

Background. The vaccine efficacy (VE) of 1 or 2 doses of AS03-adjuvanted influenza A(H1N1) vaccine relative to that of 2 doses of nonadjuvanted influenza A(H1N1) vaccine in children 6 months to <10 years of age in a multinational study conducted during 2010–2011. Methods. A total of 6145 children...

Descripción completa

Detalles Bibliográficos
Autores principales: Nolan, Terry, Roy-Ghanta, Sumita, Montellano, May, Weckx, Lily, Ulloa-Gutierrez, Rolando, Lazcano-Ponce, Eduardo, Kerdpanich, Angkool, Safadi, Marco Aurélio Palazzi, Cruz-Valdez, Aurelio, Litao, Sandra, Lim, Fong Seng, de Los Santos, Abiel Mascareñas, Weber, Miguel Angel Rodriguez, Tinoco, Juan-Carlos, Mezerville, Marcela Hernandez-de, Faingezicht, Idis, Kosuwon, Pensri, Lopez, Pio, Borja-Tabora, Charissa, Li, Ping, Durviaux, Serge, Fries, Louis, Dubin, Gary, Breuer, Thomas, Innis, Bruce L., Vaughn, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111912/
https://www.ncbi.nlm.nih.gov/pubmed/24652494
http://dx.doi.org/10.1093/infdis/jiu173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111912/
https://www.ncbi.nlm.nih.gov/pubmed/24652494
http://dx.doi.org/10.1093/infdis/jiu173

Ejemplares similares